Michael W. Retsky, Ph.D.
|Institution||Harvard School of Public Health|
|Department||EH - Molecular+Integrative Phys Sci Prog|
|Address||Harvard School of Public Health|
665 Huntington Ave
Boston MA 02115
Michael Retsky divides his activities between cancer research at HSPH and electron beam technology at a small business. (See US patent 7282727 for an example of Retsky’s involvement with electron beam technology. This invention was a patriotic reaction after 9-11 terrorist attack. It describes a "Star Wars" type ballistic missile defense. This directed energy weapon can produce trillion watt/cm2 electron energy bursts at a rate of 1 per second for weeks that could destroy a very large number of missiles and decoys within 1000 km. This rapid fire ability is allowed within Antiballistic Treaties and is far outside the capability of all other ballistic missile defenses. See http://www.google.com/patents/US7282727 ).
He is co-PI of a 3 year $600k breast cancer grant from Komen Foundation.
Retsky was apparently the first person to use low dose metronomic chemotherapy in 1994-1996 for treatment of stage IIIc colon cancer as described in the following two papers:
Retsky M, Metronomic Chemotherapy was Originally Designed and first used in 1994 for Early Stage Cancer - why is it Taking so Long to Proceed? Journal of Bioequivalence and Bioavailability, May 2011, Editorial http://www.omicsonline.org/0975-0851/JBB-Editorial6.pdf
MW Retsky; How long should adjuvant chemotherapy be given in early stage colon cancer? Clinical and Experimental Pathology. 3:1 2013.
He is on the Board of Directors of Colon Cancer Alliance (www.ccalliance.org) and Editor-in-Chief of Journal of Bioequivalence and Bioavailability.
He is Honorary Faculty, University College London, UK and Professor Adj at UANL, Monterrey, Mexico.
Email contact firstname.lastname@example.org and email@example.com
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Justin Sayde (jsaydehsph.harvard.edu).